Personalized mRNA tumor vaccine preparation system

NegotiableUpdate on 05/06

Model

Nature of the Manufacturer: Producers

Product Category

Place of Origin

Online Consult

Overview

XNano The PCV personalized mRNA tumor vaccine preparation system is a fully enclosed disposable LNP encapsulation system designed specifically for clinical research (IIT/IST) and GMP commercial production of personalized mRNA tumor vaccines. It can efficiently achieve a production scale of 40mL to 50L and support a flow rate range of 50-400mL/min (excluding dilution flow rate) and a flow rate ratio adjustment of 1:1 to 1:5.

Product Details

Personalized mRNA tumor

Vaccine manufacturing system

Model: XNano ™ PCV

XNano ™ The PCV system is a fully enclosed disposable mRNA/LNP encapsulation system designed specifically for clinical research and GMP production of mRNA personalized tumor vaccines. It canUltra high recovery rate achieved from 40ml to 50LMicrofluidic mixing and production preparation of mRNA/LNP.

XNano ™ Performance of PCV

Functional features: fully enclosed, disposable flow path, ultra-high recovery rate
Preparation volume covers40mL to 50L(Excluding diluent volume)
Chip type:Two channel/three channel/four channel hybrid chip
Mixed structure:Microfluidics or T-Mix, while supporting customization
Dilution type: online dilution/multi-stage dilution/automatic offline dilution
conform toGMP and 21CFR Part 11Waiting for relevant regulatory requirements
We can provide a complete set of GMP validation support documents in both Chinese and English (including extractable validation documents) and GMP validation activities

XNano ™ Characteristics of PCV

Only by using "chip" intelligent manufacturing can it be true

The dual algorithms of FHIR trol and ISensor use millisecond level microfluidic mixing control to accurately control and display the true flow rate in real time.

Simple and efficient, no need for cleaning verification

XNano ™ PCV does not require tedious steps such as pipeline cleaning, and it only takes 5 minutes from flow path assembly to mRNA/LNP preparation completion.

个性化mRNA肿瘤疫苗制备系统

Reduce costs and increase efficiency, drugs are accessible

Meina's microfluidic technology and process can achieve a minimum preparation volume of 40mL and a sample utilization rate of up to 98%, making drugs no longer out of reach.

个性化mRNA肿瘤疫苗制备系统

Different from others, 'art' in the future

The design of the four channel microfluidic chip by Meina not only makes multiple dilution processes a reality and meets the requirements of differentiated delivery systems, but also unlocks more application directions, such as one-step preparation of antibody conjugated LNP and Core shell structured LNP.

个性化mRNA肿瘤疫苗制备系统

<<< END >>>